Gateway Investment Advisers LLC Reduces Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Gateway Investment Advisers LLC reduced its stake by 7.0% in HCA Healthcare during Q4, selling 5,754 shares and finishing the quarter with 76,220 shares valued at about $35.58 million.
• HCA slightly missed quarterly EPS ($7.15 reported vs. $7.19 expected) while revenue rose 4.3% to $19.11 billion, and the company issued FY2026 EPS guidance of 29.10–31.50 (analysts average 30.05).
• HCA declared a quarterly dividend of $0.78 ($3.12 annualized, ~0.7% yield; ex-dividend June 16) and insiders sold 13,714 shares worth $7.05 million last quarter, with insiders owning about 1.5% of the stock.

Gateway Investment Advisers LLC lessened its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 7.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 76,220 shares of the company's stock after selling 5,754 shares during the quarter. Gateway Investment Advisers LLC's holdings in HCA Healthcare were worth $35,584,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Indivisible Partners purchased a new position in shares of HCA Healthcare during the fourth quarter valued at approximately $214,000. Stevens Capital Management LP bought a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $2,090,000. Providence First Trust Co bought a new position in HCA Healthcare in the 4th quarter valued at $754,000. Harel Insurance Investments & Financial Services Ltd. bought a new stake in shares of HCA Healthcare during the fourth quarter worth $136,000. Finally, Fairfield Financial Advisors LTD grew its holdings in shares of HCA Healthcare by 21.4% in the fourth quarter. Fairfield Financial Advisors LTD now owns 1,824 shares of the company's stock worth $851,000 after purchasing an additional 322 shares during the last quarter. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

Shares of HCA stock opened at $430.45 on Thursday. The company has a market cap of $95.49 billion, a P/E ratio of 14.80, a PEG ratio of 1.36 and a beta of 1.18. The stock's 50-day moving average is $493.48 and its 200 day moving average is $486.55. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm had revenue of $19.11 billion for the quarter, compared to analysts' expectations of $19.09 billion. The business's quarterly revenue was up 4.3% compared to the same quarter last year. During the same period in the previous year, the company posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 30.05 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is presently 10.73%.

Analyst Ratings Changes

HCA has been the topic of a number of research analyst reports. Robert W. Baird dropped their target price on shares of HCA Healthcare from $450.00 to $442.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 15th. Stephens decreased their target price on HCA Healthcare from $560.00 to $530.00 and set an "overweight" rating for the company in a research report on Monday, April 27th. Leerink Partners dropped their price target on HCA Healthcare from $573.00 to $500.00 and set an "outperform" rating on the stock in a research report on Monday, April 27th. Wall Street Zen lowered shares of HCA Healthcare from a "buy" rating to a "hold" rating in a research note on Saturday, May 2nd. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of HCA Healthcare from $558.00 to $540.00 and set a "buy" rating for the company in a report on Tuesday, April 28th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $517.82.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of the business's stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the sale, the executive vice president owned 8,853 shares of the company's stock, valued at approximately $4,721,924.61. The trade was a 16.06% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Jennifer Berres sold 8,020 shares of the firm's stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the transaction, the senior vice president directly owned 11,993 shares of the company's stock, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 13,714 shares of company stock valued at $7,050,460 in the last quarter. 1.50% of the stock is currently owned by corporate insiders.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.